Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

IMPORTANCE: Compared with the general population, patients with schizophrenia have a 2- to 3-fold higher mortality rate primarily caused by cardiovascular disease. Previous interventions designed to counteract antipsychotic-induced weight gain and cardiometabolic disturbances reported limited effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Psychiatry
Main Authors: Larsen, Julie R., Vedtofte, Louise, Jakobsen, Mathilde S. L., Jespersen, Hans R., Jakobsen, Michelle I., Svensson, Camilla K., Koyuncu, Kamuran, Schjerning, Ole, Oturai, Peter S., Kjaer, Andreas, Nielsen, Jimmi, Holst, Jens J., Ekstrøm, Claus T., Correll, Christoph U., Vilsbøll, Tina, Fink-Jensen, Anders
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710254/
https://ncbi.nlm.nih.gov/pubmed/28601891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2017.1220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados